Mustafa Khasraw

Also affiliated with Duke University, Duke Medical Center, Texas Neurology, Pediatric Brain Tumor Foundation, National Health and Medical Research Council, Duke Cancer Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “Correcting the drug development paradigm for glioblastoma requires serial tissue sampling”.

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Nature Medicine(2023)10.1038/s41591-023-02464-8

N/A

0.604DataRank · unranked

55 citations

Kelly Hotchkiss, Ian F. Parney, John de Groot, Solmaz Sahebjam, Nader Sanai +31 more

A brave new framework for glioma drug development

The Lancet Oncology(2024)10.1016/s1470-2045(24)00190-6

N/A

0.494DataRank · unranked

26 citations

Philipp Karschnia, Karisa C. Schreck, Marjolein Geurts, Timothy F. Cloughesy, Jason T. Huse +34 more

A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa146

N/A

0.457DataRank · unranked

20 citations

Tiffany R. Hodges, Nazanin Majd, Kristin Alfaro-Munoz, Wajd N. Al‐Holou, Dima Suki +15 more

A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology

Neuro-Oncology(2024)10.1093/neuonc/noae276

N/A

0.425DataRank · unranked

16 citations

Michael B. Keough, Jeffrey Zuccato, Rahul Kumar, Sebastian C Schulz, Arthur E. Warrington +14 more

Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1593

N/A

0.292DataRank · unranked

6 citations

Aaron C. Tan, Brent A. Hanks, Xiaofei Wang, Kouros Owzar, James E. Herndon +4 more

Salting the Soil: Targeting the Microenvironment of Brain Metastases

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0579

N/A

0DataRank · unranked

27 citations

Aaron C. Tan, Carey K. Anders, Ann Marie Pendergast, Dorothy A. Sipkins, David M. Ashley +3 more

The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimen

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.09.455687

N/A

0DataRank · unranked

2 citations

Thaís S. Sabedot, Indrani Datta, Luciano Garofano, Wies Vallentgoed, Frederick S. Varn +35 more

Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.03.442486

N/A

0DataRank · unranked

14 citations

Kevin C. Johnson, Taylor Wade, Tathiane M. Malta, Thaís S. Sabedot, Floris P Barthel +26 more

Reply to: ‘Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.’ by D. Fabrizio et al.

Annals of Oncology(2021)10.1016/j.annonc.2021.06.017

N/A

0DataRank · unranked

2 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +8 more

Glioma progression is shaped by genetic evolution and microenvironment interactions

Cell(2022)10.1016/j.cell.2022.04.038

N/A

0DataRank · unranked

506 citations

Kevin C. Johnson, Jan Martinek, Jason T. Huse, MacLean P. Nasrallah, Pieter Wesseling +53 more

Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma

Nature Communications(2022)10.1038/s41467-022-34175-y

N/A

0DataRank · unranked

42 citations

Jessica Waibl Polania, Molly A. Chakraborty, Jonathan Perera, Jeremy Ratiu, Alexandra Miggelbrink +9 more

Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay

Annals of Oncology(2022)10.1016/j.annonc.2022.07.009

N/A

0DataRank · unranked

8 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +8 more

A phase 1 trial of D2C7-it in combination with an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma (MG).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e14015

N/A

0DataRank · unranked

10 citations

Vidyalakshmi Chandramohan, Daniel Landi, Margaret Johnson, Mustafa Khasraw, Katherine B. Peters +12 more

The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

Cancer Research(2023)10.1158/0008-5472.can-23-2093

N/A

0DataRank · unranked

57 citations

Thaís S. Sabedot, Natalia S. Morosini, Indrani Datta, Luciano Garofano, Wies Vallentgoed +67 more

National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities

The Lancet Oncology(2023)10.1016/s1470-2045(23)00297-8

N/A

0DataRank · unranked

39 citations

Minesh P. Mehta, Dee Dee Smart, Patricia S. Steeg, Julie A. Hong, Michael Graham Espey +39 more

Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference

The Lancet Oncology(2023)10.1016/s1470-2045(23)00005-0

N/A

0DataRank · unranked

26 citations

Mei‐Yin C. Polley, Laura Alder, Priscilla K. Brastianos, Carey K. Anders, Hussein A. Tawbi +9 more

Characterization of industry relationships in oncology

Cancer(2023)10.1002/cncr.34852

N/A

0DataRank · unranked

3 citations

Nazanin Majd, Margaret Johnson, Diana L. Urbauer, Vinay K. Puduvalli, Mustafa Khasraw +1 more

Data from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

(2023)10.1158/1078-0432.c.6531102.v1

N/A

0DataRank · unranked

0 citations

Shiyou Wei, Milan R. Savani, Xiang Lin, Kuang Du, Ilgen Mender +33 more

Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions

Journal of Neuro-Oncology(2024)10.1007/s11060-024-04881-2

N/A

0DataRank · unranked

24 citations

Ahmad Ozair, Mustafa Khasraw, Graeme F. Woodworth, Pallavi Tiwari, Manmeet S. Ahluwalia +2 more

Chimeric antigen receptor T-cell therapy in patients with malignant glioma—From neuroimmunology to clinical trial design considerations

Neuro-Oncology(2024)10.1093/neuonc/noae203

N/A

0DataRank · unranked

11 citations

Jacob S. Young, Sarah Cook Quackenbush, Mustafa Khasraw, John de Groot, Hideho Okada +1 more

Enhancing adoptive cell therapy: future strategies for immune cell radioprotection in neuro-oncology

npj Precision Oncology(2025)10.1038/s41698-025-01059-5

N/A

0DataRank · unranked

7 citations

Mustafa Khasraw, James D. Byrne, Zachary J. Reitman, Adam Groth

IL-7–mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models

Journal of Clinical Investigation(2025)10.1172/jci181471

N/A

0DataRank · unranked

5 citations

Kelly Hotchkiss, Sarah Cook, Pamy Noldner, Ying Zhou, Eliese Moelker +12 more

PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1135

N/A

0DataRank · unranked

126 citations

David A. Reardon, Michael Weller, John H. Sampson, Mustafa Khasraw

A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL Expansion

Research Square(2025)10.21203/rs.3.rs-6314842/v1

N/A

0DataRank · unranked

1 citations

Kelly Hotchkiss, Kenan Zhang, A Corcoran, Elizabeth B. Owens, Pamela Noldner +16 more

High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types

Annals of Oncology(2021)10.1016/j.annonc.2021.02.006

N/A

0DataRank · unranked

1067 citations

P.G. Pilié, N.U. Rashid, Leonie Voorwerk, Maarten Slagter, Marleen Kok +11 more

Leveraging external data in the design and analysis of clinical trials in neuro-oncology

The Lancet Oncology(2021)10.1016/s1470-2045(21)00488-5

N/A

0DataRank · unranked

85 citations

Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes‐Rivera, Mei‐Yin C. Polley +14 more

Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002459

N/A

0DataRank · unranked

83 citations

Stephen Bagley, Patrick Y. Wen, Michael Lim, Michael Platten, Howard Colman +16 more

A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0374

N/A

0DataRank · unranked

30 citations

Shiyou Wei, Milan R. Savani, Xiang Lin, Kuang Du, Ilgen Mender +33 more